BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2015
View Archived Issues
Grant awarded to Euroscreen for research into GPCR-targeted neurodegenerative disease treatments
Read More
Isis Pharmaceuticals advances ISIS-SMNRx in infants with spinal muscular atrophy
Read More
VolitionRx initiates Belgian study to investigate NuQ for detection of prostate cancer
Read More
ValiRx raises funding to support key programs
Read More
Pharmacokinetics of topical umeclidinium for hyperhidrosis determined
Read More
New development strategy formulated for Diabecell
Read More
Norgine and Navidea sign European commercialization and distribution agreement for Lymphoseek
Read More
RaQualia signs collaboration agreement with the Nagoya University
Read More
PoC study results support efficacy of lonafarnib in patients with HDV
Read More
Novel acylguanidine-based small molecule inhibits HIV-1 replication
Read More
Epigenetic inhibitor induces resensitization to irinotecan-based therapies
Read More
R-Tech Ueno regains all licenses to unoprostone, reports phase III data
Read More
Targacept and Catalyst Biosciences merge to create protease-based hemostasis company
Read More
ContraVir Pharmaceuticals to begin pivotal phase III study of FV-100
Read More
CTI BioPharma and Baxter report topline data from phase III Persist-1 trial of pacritinib
Read More
Indian CSIR patents new anticancer agents
Read More
Mallinckrodt Pharmaceuticals to expand hospital growth platform with Ikaria acquisition
Read More
Allergan discloses S1P1 modulators
Read More
University of Warsaw divulges neuropilin-1 antagonists
Read More
Heat Biologics receives FDA fast track designation for HS-410 in combination with BCG
Read More
Substance abuse candidate GS-6637 well tolerated in healthy volunteers
Read More
Merck & Co. patents LRRK2 inhibitors
Read More
Vanderbilt University patent describes muscarinic M4 receptor PAMs
Read More
Domain Therapeutics launches Kaldi Pharma to develop its adenosine programs
Read More
Alfa Wassermann and Sigma-Tau to create new company
Read More
Rosuvastatin/ezetimibe fixed-dose combination bioequivalent to coadministration of each drug
Read More